Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Corti

Showing results (151-160 of 202) with videos related to

Pageof 21
Sort By:
SSRN|July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Plos One|January 26, 2010
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individualsDavide Corti, Johannes P M Langedijk, Andreas Hinz, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Research Square|May 20, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsMichael Diamond, Rita Chen, Emma Winkler, et al.
Cell Host & Microbe|August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Cell Reports|June 24, 2021
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7Bo Meng, Steven A Kemp, Guido Papa, et al.
Science (New York, N.Y.)|January 6, 2022
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.
Science (New York, N.Y.)|February 27, 2016
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibodyDavide Corti, John Misasi, Sabue Mulangu, et al.
Pageof 21

Showing results (151-160 of 202) with videos related to

Sort By:
Pageof 21
SSRN|July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Plos One|January 26, 2010
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individualsDavide Corti, Johannes P M Langedijk, Andreas Hinz, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Research Square|May 20, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsMichael Diamond, Rita Chen, Emma Winkler, et al.
Cell Host & Microbe|August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Cell Reports|June 24, 2021
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7Bo Meng, Steven A Kemp, Guido Papa, et al.
Science (New York, N.Y.)|January 6, 2022
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.
Science (New York, N.Y.)|February 27, 2016
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibodyDavide Corti, John Misasi, Sabue Mulangu, et al.
Pageof 21